Correlation Between Catalyst Pharmaceuticals and Alvotech
Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and Alvotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and Alvotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Catalyst Pharmaceuticals and Alvotech, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and Alvotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of Alvotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and Alvotech.
Diversification Opportunities for Catalyst Pharmaceuticals and Alvotech
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Catalyst and Alvotech is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and Alvotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alvotech and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with Alvotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alvotech has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and Alvotech go up and down completely randomly.
Pair Corralation between Catalyst Pharmaceuticals and Alvotech
Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to generate 1.28 times less return on investment than Alvotech. In addition to that, Catalyst Pharmaceuticals is 1.03 times more volatile than Alvotech. It trades about 0.03 of its total potential returns per unit of risk. Alvotech is currently generating about 0.04 per unit of volatility. If you would invest 791.00 in Alvotech on September 2, 2024 and sell it today you would earn a total of 384.00 from holding Alvotech or generate 48.55% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Catalyst Pharmaceuticals vs. Alvotech
Performance |
| Timeline |
| Catalyst Pharmaceuticals |
| Alvotech |
Catalyst Pharmaceuticals and Alvotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Catalyst Pharmaceuticals and Alvotech
The main advantage of trading using opposite Catalyst Pharmaceuticals and Alvotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, Alvotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alvotech will offset losses from the drop in Alvotech's long position.| Catalyst Pharmaceuticals vs. Day One Biopharmaceuticals | Catalyst Pharmaceuticals vs. Terns Pharmaceuticals | Catalyst Pharmaceuticals vs. X4 Pharmaceuticals | Catalyst Pharmaceuticals vs. Inozyme Pharma |
| Alvotech vs. Intracellular Th | Alvotech vs. Catalent | Alvotech vs. Amphastar P | Alvotech vs. Assertio Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |